Per thor Straten | Scientific Advisor and co-founder
Per thor Straten has an MSc in Biology and is a Clinical Professor at the University of Copenhagen. He is a scientific adviser to the company, and a co-founder of RhoVac. Straten has extensive research experience in the fields of immunotherapy, specifically therapeutic cancer vaccines. Mr. Straten has authored numerous scientific articles relating to tumour immunology and immunotherapy. He was involved in the successful exit of SurVac ApS.